Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity
Version of Record online: 7 NOV 2011
© 2011 Japanese Cancer Association
Volume 103, Issue 1, pages 107–115, January 2012
How to Cite
Wang, Y.-Y., Taniguchi, T., Baba, T., Li, Y.-Y., Ishibashi, H. and Mukaida, N. (2012), Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity. Cancer Science, 103: 107–115. doi: 10.1111/j.1349-7006.2011.02117.x
- Issue online: 6 JAN 2012
- Version of Record online: 7 NOV 2011
- Accepted manuscript online: 10 OCT 2011 04:31AM EST
- (Received June 28, 2011/Revised October 5, 2011/Accepted October 6, 2011/Accepted manuscript online October 10, 2011/Article first published online November 8, 2011)
Fig. S1. Effects of T26 treatment on various parameters in tumor-bearing mice.
|CAS_2117_sm_fS1.tif||266K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.